Shemesh, Colby S.
Agarwal, Priya
Lu, Tong
Lee, Calvin
Dere, Randall C.
Li, Xiaobin
Li, Chunze
Jin, Jin Y.
Girish, Sandhya
Miles, Dale
Lu, Dan
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd
Article History
Received: 4 October 2019
Accepted: 3 March 2020
First Online: 28 March 2020
Compliance with ethical standards
:
: This study was sponsored by Genentech, Inc and F. Hoffmann-La Roche Ltd. All study authors are employees and stockholders of Genentech, Inc and F. Hoffmann-La Roche Ltd.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The first ethics committee approval was granted on 15 October 2013 from the Oncology Associates of Oregon, P.C., Willamette Valley Cancer Institute. This site granted approval for the trial in addition to other multiple ethics committees/institutional review board approvals obtained across other sites and countries of enrollment.
: Informed consent was obtained from all individual participants included in the study.